IP Library Assignment 029315/0495
Patent Assignment
Reel/Frame 029315/0495

Assignment of Assignor's Interest

Recorded: 2012-11-16 Pages: 3
Assignor
ABELA PHARMACEUTICALS, INC.
Executed: 2012-08-18
Assignee
CARDINAL ASSOCIATES, INC.
1000 WEST 8TH STREET, VANCOUVER, WASHINGTON, 98660
Covered Property (1)
Methods of Sensitizing Drug Resistant Microorganisms Using Methylsulfonylmethane (Msm)
Patent: 8,546,373 →
Application: 13/458,907 →
Publication: US 2012/0264726
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 16, 2012
From: CARDINAL ASSOCIATES, INC.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 029315/0549 →
Assignment of Assignor's Interest Jul 2, 2013
From: COZEAN, COLETTE; BENJAMIN, RODNEY; KELLER, ANTHONY; VARELMAN, JEFFREY
To: TANDEM-ABELA DEVELOPMENT GROUP, LLC
Reel/Frame 030731/0650 →
Assignment of Assignor's Interest Jul 2, 2013
From: TANDEM-ABELA DEVELOPMENT GROUP, LLC
To: ABELA PHARMACEUTICALS, INC.
Reel/Frame 030746/0397 →
Merger Jun 11, 2024
From: CARDINAL ASSOCIATES, INC.
To: ALBION LABORATORIES, INC.
Reel/Frame 067695/0404 →
Asset Assignment Agreement Jun 11, 2024
From: BIOGENIC INNOVATIONS, LLC
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 067698/0938 →
Security Interest Jul 24, 2026
From: ALBION LABORATORIES, INC.; BALCHEM CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075393/0698 →